Second
Quarter 1999 Financial Summary
Management
Discussion
Balance Sheets
Statements of Loss and Deficit
Statement of Changes in Financial Position
Management Discussion - Top of Page
There are more signs that the semiconductor industry is recovering from the downturn and our outlook continues to be positive. Industry awareness and interest in our products and technology is growing and we have been focusing our efforts on securing major orders, forging strategic relationships, and maintaining our technical leadership in equipment health monitoring and advanced fault detection software solutions.
During the end of the second quarter, Triant announced two major accomplishments:
-
Receipt of a $2.0 million purchase order from a leading multinational semiconductor manufacturer for deployment of ModelWare/RT
- Completion of a strategic partnership with Applied Materials, Inc. (NASDAQ: AMAT), a fortune 500 global growth company and the world's largest supplier of wafer fabrication systems and services to the global semiconductor industry
The $2.0 million purchase order followed extensive testing and evaluation of ModelWare/RT at one of the customer's wafer fabrication plants (fabs). The purchase order is for deployment at two of the customer's production fabs and consists of two phases. In the first phase, Triant will integrate ModelWare/RT into the customer's existing computer integrated manufacturing (CIM) environment (expected to be completed in the second half of 1999). In the second phase, Triant will deploy ModelWare/RT mainly on the customer's etch and deposition equipment and provide product training and technical support (expected to be completed in the first half of 2000). This substantial order clearly demonstrates the value that Triant's equipment health monitoring and fault detection software brings to the semiconductor industry as semiconductor manufacturers realize the need to improve fab productivity by reducing scrap and increasing equipment utilization.
The strategic partnership with Applied Materials consists of two definitive agreements. Under a private placement agreement, Applied Materials acquired a 12.5 percent equity interest in Triant for an investment of $2.2 million. Under a separate license agreement, Applied Materials became the exclusive value-added reseller (VAR), in the semiconductor industry, of Triant's equipment health monitoring and fault detection software technology. Under the terms of the license agreement, Applied Materials has been granted the right to market a future version of Triant's ModelWare/RT, with its own products and services. Triant will receive a fee for each license shipped. Triant will continue to license its end user version of ModelWare/RT to semiconductor manufacturers for retrofit on all makes and models of wafer processing equipment using existing and new distribution channels. In addition, Triant retains all rights to license its software technology for use in other industries. This joint effort by Applied Materials and Triant will focus on helping customers better address the rapidly increasing requirement for higher overall productivity in their fabs.
Triant's second quarter financial results are as follows:
- Revenue for the six months ended June 30, 1999 was $309,640 (compared to $214,642 for the six months ended June 30, 1998). The increase in revenue was attributable to orders for our principal product, ModelWare/RT, both from direct sales and through our European distributor, Metron Technology.
- Costs and expenses for the six months ended June 30, 1999 were $1,041,420 (compared to $2,415,503 for the six months ended June 30, 1998). This 57% decrease in expenses is a result of the Company's restructuring decision in mid-1998 to focus on core development activities, eliminate certain direct sales and marketing activities, reduce management, sales and marketing, and non-core product development staff, and close excess facilities.
- Loss from operations and net loss for the six months ended June 30, 1999 were $731,780 (compared to loss from operations and net loss of $2,200,861 for the six months ended June 30, 1998). This 67% decrease in loss from operations and net loss for the six months ended June 30, 1999 reflects the combination of an increase in revenue and a significant decrease in costs and expenses. The loss per share for the six months ended June 30, 1999 was $0.04 (compared to a loss per share of $0.17 for the six months ended June 30, 1998). This 76% decrease in loss per share resulted from the combination of a lower net loss and a higher number of shares outstanding.
- At June 30, 1999, cash and cash equivalents were $2,318,588 (compared to $253,310 at June 30, 1998), working capital was $2,071,731 (compared to working capital deficiency of $537,588 at June 30, 1998), assets were $3,025,934 (compared to $676,293 at June 30, 1998), and shareholders' equity was $1,667,785 (compared to capital deficiency of $778,354 at June 30, 1998). Since the beginning of 1999, the Company has raised approximately $3.1 million in equity financing.
Subsequent to end of the second quarter, Triant reported that:
- Philips Semiconductors MOS4YOU wafer fab in Nijmegen, The Netherlands, has selected Triant's ModelWare/RT as their strategic Equipment health monitoring and Fault Detection solution for their entire metal etch section. Philips Semiconductors is also considering ModelWare/RT for other sections in its fab. Metron Technology, Triant's European distributor, is providing all ModelWare/RT sales, installation, and support services to Philips Semiconductors
- Domain Logix Corporation had signed a distribution agreement for the sales, installation, and support of Triant's ModelWare/RT software to end-users in the U.S. semiconductor industry. Domain Logix, a private company headquartered in Austin, Texas, delivers solutions to the semiconductor industry to maximize their customer's return on investment in terms of improved yield, quality, cycle-time, and cost.
Triant's management and strategic focus for the foreseeable future is to increase revenue and generate net earnings from the semiconductor industry by being the leading supplier of equipment health monitoring and advanced fault detection software solutions, offering value-added customer support services and leveraging the skills and resources of world-wide distribution channel partners. Triant is a technological leader uniquely positioned to capitalize on the semiconductor industry's growing demand to improve fab productivity.
Certain of above statements include forward-looking statements involving risks and uncertainties which may cause the actual results, performance or achievements of the Company to be materially different from those implied by such forward-looking statements. Please refer to a discussion of these and other factors in the Company's 20-F, 6-K, Annual Information Form and other filings with United States, British Columbia and Ontario securities regulatory authorities.
Consolidated Balance Sheets - Top of Page
| TRIANT TECHNOLOGIES INC. |
| Consolidated Balance Sheets |
June 30
(Expressed in Canadian Dollars) |
|
| (unaudited) |
| 1999 | 1998 |
|
|
| ASSETS |
|
| CURRENT |
| Cash and cash equivalents | | $ 2,318,588 | | $ 253,310 |
| Accounts receivable | 583,680 | 47,263 |
| Share subscriptions receivable | 13,461 | 177,178 |
| Prepaid expenses and deposits | 18,747 | 10,892 |
|
| 2,934,476 | 488,643 |
| Capital assets | 91,458 | 187,650 |
|
| | $ 3,025,934 | | $ 676,293 |
|
| LIABILITIES |
|
| CURRENT |
| Accounts payable and accrued liabilities | | $ 491,490 | | $ 980,312 |
| Deferred revenue | 371,255 | 45,919 |
|
|
862,745 |
1,026,231 |
| Liability component of convertible debentures | 495,404 | 428,416 |
|
| 1,358,149 | 1,454,647 |
|
|
|
| SHAREHOLDERS' EQUITY |
|
| Equity component of convertible debentures | 400,000 | 400,000 |
| Share capital | 14,874,354 | 10,338,822 |
| Share subscriptions | 21,250 | 489,105 |
| Deficit | (13,627,819) | (12,006,281) |
|
| 1,667,785 | (778,354) |
|
|
|
$ 3,025,934 |
|
$ 676,293 |
|
|
| APPROVED BY THE BOARD OF DIRECTORS |
|
| (Signed) David L. Baird | (Signed) Paul J. O'Sullivan |
| David L. Baird, Director | Paul J. O'Sullivan, Director |
Consolidated
Statements of Loss and Deficit - Top of Page
| TRIANT TECHNOLOGIES INC. |
| Consolidated Statements of Loss and Deficit |
Six Months ended June 30
(Expressed in Canadian Dollars) |
|
| (unaudited) |
| 1999 | 1998 |
|
|
| REVENUE | | $ 309,640 | | $ 214,642 |
|
|
| COSTS AND EXPENSES |
| Amortization | 19,828 | 44,589 |
| Direct costs and expenses | 76,049 | 202,804 |
| General and administrative | 312,265 | 601,258 |
| Interest on convertible debentures | 73,140 | 68,448 |
| Marketing, sales and communications | 205,490 | 629,932 |
| Research and development | 354,648 | 742,250 |
| Restructuring charges | - | 126,222 |
|
| 1,041,420 | 2,415,503 |
|
|
| LOSS FROM OPERATIONS AND |
| NET LOSS FOR THE PERIOD | (731,780) | (2,200,861) |
|
| Deficit, beginning of period | (12,896,039) | (9,805,420) |
| Deficit, end of period | | $ (13,627,819) | | $ (12,006,281) |
|
|
| Loss per share | | $ (0.04) | | $ (0.17) |
|
Consolidated
Statements of Changes in Financial Position - Top of Page
| TRIANT TECHNOLOGIES INC. |
| Consolidated Statements of Changes in Financial Position |
Six Months ended June 30
(Expressed in Canadian Dollars) |
|
| (unaudited) |
| 1999 | 1998 |
|
|
| OPERATING ACTIVITIES |
| Loss from operations and net loss for the period | | $ (731,780) | | $ (2,200,861) |
| Items not requiring cash |
| Amortization | 19,828 | 44,589 |
| Accretion of liability component |
| of convertible debentures | 34,710 | 30,016 |
|
| (677,242) | (2,126,256) |
| Changes in operating assets and liabilities | (225,329) | 751,681 |
|
| (902,571) | (1,374,575) |
|
|
| FINANCING ACTIVITIES |
| Share capital, net of issue costs | 3,083,289 | 205,275 |
| Share subscriptions | (14,448) | 258,906 |
|
| 3,068,841 | 464,181 |
|
|
| INVESTING ACTIVITY |
| Capital assets | (9,555) | - |
|
| Increase (decrease) in cash and cash equivalents |
| during the period | 2,156,715 | (910,394) |
|
| Cash and cash equivalents, beginning of period | 161,873 | 1,163,704 |
|
| Cash and cash equivalents, end of period | | $ 2,318,588 | | $ 253,310 |
|
|